Nov. 16, 2018—In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have identified several of the conditions that arise and have determined that they usually appear early in treatment.
Nov. 1, 2018—Jeffrey Rathmell and colleagues show that a drug that inhibits glutamine metabolism — currently in clinical trials as an anticancer agent — might also be useful as a treatment for inflammatory and autoimmune diseases.
Oct. 29, 2018—This work was the foundation for an NSF grant to interrogate how the Rif1 protein controls DNA replication.
Oct. 26, 2018—A new link between a support protein within the brain's white matter and known Alzheimer's biomarkers discovered by Angela Jefferson and colleagues bring researchers a step toward earlier and more precise detection of neuropathology underlying cognitive impairment that may lead to new targeted therapies
Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of a heart attack, report Eric Gamazon, Sandra Zinkel and graduate students Christie Salisbury-Ruf and Clinton Bertram in new research.
Oct. 11, 2018—The hidden lives of medical biomarkers are the focus of a recent study in Nature Communications by Jonathan Mosley.
Oct. 5, 2018—Patricia and Rodes Hart Professor of Special Education Laurie Cutting has received a $3 million NIH Merit Award from the National Institute of Child Health and Human Development.
Oct. 4, 2018—Reyna Gordon has received a NIH Director’s New Innovator Award of $2.3 million for her project, “Biomarkers of Rhythmic Communication: Integrating Foundational and Translational Approaches.”